Home › Funds › Royce & Associates › NLTX
Royce & Associates position in NLTX
NEOLEUKIN THERAPEUTICS INC
Latest position (Q3 2022)145.40K sh
Reported value held$93.00K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 145.40K | $1.05M | New |
| Q4 2021 | 145.40K | $701.00K | Hold |
| Q1 2022 | 145.40K | $273.00K | Hold |
| Q2 2022 | 145.40K | $150.00K | Hold |
| Q3 2022 | 145.40K | $93.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.